Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 Meeting Abstract
| Authors: | Manders, P.; Joshua, A. M.; Kefford, R.; Robert, C.; Ribas, A.; Hamid, O.; Daud, A.; Wolchok, J. D.; Hwu, W. J.; Weber, J. S.; Gangadhar, T. C.; Joseph, R.; Dronca, R.; Patnaik, A.; Zarour, H.; Hersey, P.; Li, X. N.; Diede, S. J.; Ebbinghaus, S.; Hodi, F. S. |
| Abstract Title: | Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 |
| Meeting Title: | 2016 Annual Scientific Meeting of the Medical Oncology Group of Australia Incorporated (MOGA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 12 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2016 Aug 3-5 |
| Meeting Location: | Gold Coast, Queensland |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-08-01 |
| Start Page: | 47 |
| End Page: | 48 |
| Language: | English |
| ACCESSION: | WOS:000380005100012 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.12542 |
| PUBMED: | 27435141 |
| Notes: | Meeting Abstract -- Source: Wos |
